Balance Sheet Components (Tables)

12 Months Ended

Dec. 31, 2024

Balance Sheet Related Disclosures [Abstract]

Summary of Property and Equipment

The following summarizes property and equipment, net as of December 31, 2024 and 2023 (in thousands):


		December 31, 2024				December 31, 2023
Equipment		$	110,011			$	91,656
Leasehold improvements			46,809				42,433
Furniture and fixtures			6,633				6,633
Total property and equipment, gross			163,453				140,722
Less: accumulated depreciation			(105,397	)			(79,041	)
Property and equipment, net		$	58,056			$	61,681

Summary of Depreciation Expenses on Property and Equipment

Depreciation expense on property and equipment is classified as follows in the accompanying consolidated statements of operations for the years ended December 31, 2024, 2023 and 2022 (in thousands):


		Year Ended December 31,
		2024				2023				2022
Cost of revenue, genomics		$	13,966			$	12,961			$	8,190
Cost of revenue, data and services			172				—				—
Research and development			—				—				1,371
Selling, general and administrative costs			12,218				8,318				7,133
Total depreciation		$	26,356			$	21,279			$	16,694

Summary of Accrued Expenses

Accrued expenses as of December 31, 2024 and 2023, consist of the following (in thousands):


		December 31, 2024				December 31, 2023
Accrued compensation and employee benefits		$	24,767			$	21,950
Accrued expenses			51,147				37,783
Accrued employer payroll tax related to stock-based compensation			24,439				—
Accrued cloud storage costs			21,394				13,921
Interest payable			8,660				8,863
Total accrued expenses		$	130,407			$	82,517